Drug Target Review Antibodies ebook 2021
This ebook has features on the development of intranasally-delivered antibodies to combat SARS-CoV-2 and how the structure of a nanobody was determined using nuclear magnetic resonance methods.
In this collection of articles, Dr Steve Carroll explains why antibody therapeutics continue to be required in the fight against COVID-19. He also outlines recent research into an Immunoglobulin M (IgM) antibody platform that could combat SARS‑CoV-2 and its variants.
In a Q&A, Professor Gennaro Esposito discusses nanobodies and why this class of small protein, derived from antibodies occurring in camelids and sharks, has the potential to fight a wide range of diseases.
Included in this ebook:
- An IgM antibody platform to tackle SARS‑CoV-2 and its variants
Dr Steve Carroll, IGM Biosciences
- Determining the structure of nanobodies using nuclear magnetic resonance spectroscopy
Professor Gennaro Esposito, New York University (NYU) Abu Dhabi